A patient got the weight loss medication retatrutide before FDA approval. How does that work? ^6.3%

PolitiFact - By Madison Czopek - 7/1/2026, 12:00 AM

Appeal to Authority 15.2% - Ambiguity (Equivocation) 9.7% - Hasty Generalization 9.4%

Eli Lilly's experimental weight loss drug retatrutide is in the news after an unidentified 79-year-old got early access. Although the U.S Food and Drug Administration has not approved the drug, the agency and drugmaker Eli Lilly allowed one patient to get the drug early through a method commonly called "compassionate use," the health... more